Name : CBL2 (Tyr731) Antibody
Supplier : BIOSS PRIMARY UNCONJUGATED ANTIBODIES
Price :281
SKU : GEN3146670069
| Long name | CBL2 (Tyr731) Primary Polyclonal Antibody |
| Also known as | CBL2 (Tyr731) PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | CBL2 Tyr731 |
| Specificity | This is a highly specific antibody against CBL2 Tyr731 |
| Modification(s) | Phosphorylation |
| Modification site(s) | Tyr731 |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Source | KLH conjugated synthetic phosphopeptide derived from human CBL2 around the phosphorylation site of Tyr731 |
| Gene ID number | 867 |
| Tested Applications | IF(IHC-P), IHC-P, WB |
| Recommended dilutions | IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity | Mouse, Rat, Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | An additional mechanism to attenuate receptor signaling is thought to be achieved by CBLâ, In more recent studies CBL has been shown to be a negative regulator of tyrosine kinase signaling, Targets of CBL include activated protein tyrosine kinases belonging to the Src and Syk/Zap 70 families, The ubiquitin ligase activity of CBL leads to the degradation of tyrosine kinases, such as PI 3K and Vav, thus attenuating the signal of receptors, &euro, &trade, The proto oncogene c CBL was initially identified as the cellular homologue of v CBL oncogene that induces pre B cell lymphomas and myeloid leukemias in mice, s interaction with downstream targets of tyrosine kinases |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | 4732447J05Rik, C CBL, CBL 2, CBL2 Tyr731, CBL2 Tyr731, CBL_HUMAN, Cas-Br-M murine ecotropic retroviral transforming sequence, Casitas B lineage lymphoma proto oncogene, Oncogene CBL2, Proto oncogene c CBL, RGD1561386, RING finger protein 55, RNF55v Signal transduction protein CBL, p-CBL2 Tyr731, p-CBL2 Y731, C CBL Tyr731, E3 ubiquitin protein ligase CBL |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | CBL2 (Tyr731) |
| Short name | CBL2 (Tyr731) Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | CBL2 (Tyr731) (Antibody to) |
| Alternative technique | antibodies |
| Identity | 1541 |
| Gene | CBL |
| Long gene name | Cbl proto-oncogene |
| Synonyms gene | CBL2 |
| Synonyms gene name | Cas-Br-M (murine) ecotropic retroviral transforming sequence Cbl proto-oncogene, E3 ubiquitin protein ligase |
| Synonyms | RNF55 c-Cbl |
| Synonyms name | oncogene CBL2 |
| Locus | 11q23, 3 |
| Discovery year | 1989-06-30 |
| GenBank acession | X57110 |
| Entrez gene record | 867 |
| Pubmed identfication | 2013228 |
| RefSeq identity | NM_005188 |
| Classification | Ring finger proteins |
| Havana BLAST/BLAT | OTTHUMG00000166170 |
| Locus Specific Databases | LRG_608 |